ODD stock news
This page provides real-time market news, earnings updates, and company announcements related to Odd Burger Corporation (ODD).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-04-04 14:18 EST
QQQ Options Signal Deep Put Bias and Bearish Skew as Traders Eye $580 Support and $620 Resistance
101 finance2026-03-19 17:31:02
Oddity Tech Faces Legal Overhang and Cost Shock—Is This a Setup for a Squeeze-Play Rebound?
101 finance2026-03-19 18:21:38
ODDITY Faces Binary Test: Does Q1 Revenue Decline Signal a Brief Setback or a Fundamental Breakdown in Its AI Growth Narrative?
101 finance2026-03-20 18:30:59
ODDITY Tech Shares Plunge 49%: Is This a Lasting Downturn or a Short-Term Setback?
101 finance2026-03-20 19:06:58
Oddity Tech Faces Broken Growth Model as Insiders Sell and Legal Storm Brews
101 finance2026-03-23 05:39:39
Oddity Tech Faces Existential Legal and Operational Crossroads as May 11 Deadline Looms
101 finance2026-03-23 05:42:42
SCHOLASTIC CORPORATION ANNOUNCES CASH TENDER OFFER TO PURCHASE UP TO $200 MILLION OF ITS COMMON STOCK
Finviz2026-03-23 12:03:50
Circle Internet Group (Ondo Tokenized Stock) Price Review and Recent Market Trends
101 finance2026-03-23 17:15:56
Oddity Tech’s Legal Overhang and Cost Crisis: Is the 49% Crash a Mispriced Recovery Play?
101 finance2026-03-23 17:25:17
Tesla - Is minor A complete? Or will we get another low first
TradingView2026-03-24 07:45:20
CATX Surges 15.5% on Gap Move, But No Clear Catalyst
101 finance2026-03-24 12:42:35
ANNA Surges 24% Amid Energy Volatility, Not Company News
101 finance2026-03-24 13:03:47
Sanara Medtech’s Earnings Call Contradictions: Growth Outlook Shifts and THP Partnership Timelines Clash
101 finance2026-03-24 13:12:57
OS Therapies Granted EMA's Advanced Therapy Medicinal Product (ATMP) Designation for OST-HER2 in the Treatment of Pulmonary Recurrence in Resected Osteosarcoma
Finviz2026-03-25 10:01:02
OS Therapies Granted Meetings with U.S. FDA, U.K. MHRA, EMA and Australian Therapeutic Goods Administration to Review Global Confirmatory Phase 3 Trial for OST-HER2 in Metastatic Osteosarcoma
Finviz2026-03-27 10:00:45
Unicycive Therapeutics Announces Full Year 2025 Financial Results and Provides Business Update
Finviz2026-03-30 11:09:44
Praxis Precision Medicines Announces FDA Acceptance and Priority Review of New Drug Application for Relutrigine in Patients with SCN2A and SCN8A DEEs
Finviz2026-03-30 20:06:12
OS Therapies Completes Submission of Biomarker & Clinical Data for U.S. FDA Pre-BLA Meeting, Reports Full Year 2025 Financial Results and Provides Business Update
Finviz2026-03-31 11:42:53
ODDITY Tech Faces Existential Test: Algorithm Change Exposes Fragility in Core Advertising Model as Legal and Operational Risks Converge
101 finance2026-04-01 20:18:42
Will NextTrip, Inc. be the next 1000x? The QUBT Crowd is Back.
TradingView2026-04-01 21:09:29
OS Therapies Completes $5.25M Registered Direct Offering Primarily with Pre-Existing High-Net-Worth Investors
Finviz2026-04-02 21:18:49
Scott Bok Breaks Down the Daily Responsibilities of Investment Bankers | Odd Lots
101 finance2026-04-03 13:09:43
ODD CEO Repurchases Shares at 80% Off—Insiders Exit Rapidly
101 finance2026-04-03 20:09:44
SEC Issues Alert on Impersonation Scams Amid Securities Fraud Accusations Against Several Firms
101 finance2026-04-04 03:48:49
Oddity Tech Faces Broken Growth Model as Insiders Sell and Legal Storm Brews
101 finance2026-03-23 05:39:39
Oddity Tech Faces Existential Legal and Operational Crossroads as May 11 Deadline Looms
101 finance2026-03-23 05:42:42
SCHOLASTIC CORPORATION ANNOUNCES CASH TENDER OFFER TO PURCHASE UP TO $200 MILLION OF ITS COMMON STOCK
Finviz2026-03-23 12:03:50
Circle Internet Group (Ondo Tokenized Stock) Price Review and Recent Market Trends
101 finance2026-03-23 17:15:56
Oddity Tech’s Legal Overhang and Cost Crisis: Is the 49% Crash a Mispriced Recovery Play?
101 finance2026-03-23 17:25:17
Tesla - Is minor A complete? Or will we get another low first
TradingView2026-03-24 07:45:20
CATX Surges 15.5% on Gap Move, But No Clear Catalyst
101 finance2026-03-24 12:42:35
ANNA Surges 24% Amid Energy Volatility, Not Company News
101 finance2026-03-24 13:03:47
Sanara Medtech’s Earnings Call Contradictions: Growth Outlook Shifts and THP Partnership Timelines Clash
101 finance2026-03-24 13:12:57
OS Therapies Granted EMA's Advanced Therapy Medicinal Product (ATMP) Designation for OST-HER2 in the Treatment of Pulmonary Recurrence in Resected Osteosarcoma
Finviz2026-03-25 10:01:02
OS Therapies Granted Meetings with U.S. FDA, U.K. MHRA, EMA and Australian Therapeutic Goods Administration to Review Global Confirmatory Phase 3 Trial for OST-HER2 in Metastatic Osteosarcoma
Finviz2026-03-27 10:00:45
Unicycive Therapeutics Announces Full Year 2025 Financial Results and Provides Business Update
Finviz2026-03-30 11:09:44
Praxis Precision Medicines Announces FDA Acceptance and Priority Review of New Drug Application for Relutrigine in Patients with SCN2A and SCN8A DEEs
Finviz2026-03-30 20:06:12
OS Therapies Completes Submission of Biomarker & Clinical Data for U.S. FDA Pre-BLA Meeting, Reports Full Year 2025 Financial Results and Provides Business Update
Finviz2026-03-31 11:42:53
ODDITY Tech Faces Existential Test: Algorithm Change Exposes Fragility in Core Advertising Model as Legal and Operational Risks Converge
101 finance2026-04-01 20:18:42
Will NextTrip, Inc. be the next 1000x? The QUBT Crowd is Back.
TradingView2026-04-01 21:09:29
OS Therapies Completes $5.25M Registered Direct Offering Primarily with Pre-Existing High-Net-Worth Investors
Finviz2026-04-02 21:18:49
Scott Bok Breaks Down the Daily Responsibilities of Investment Bankers | Odd Lots
101 finance2026-04-03 13:09:43
ODD CEO Repurchases Shares at 80% Off—Insiders Exit Rapidly
101 finance2026-04-03 20:09:44
SEC Issues Alert on Impersonation Scams Amid Securities Fraud Accusations Against Several Firms
101 finance2026-04-04 03:48:49
ODD stock chart
ODD stock detailsODD stock price change
On the last trading day, ODD stock closed at 0.04 CAD, with a price change of 0.00% for the day.
Trade stock perpsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more